by [email protected] | Jul 28, 2022 | News & Events
The STATinMED team co-authored 1 poster accepted for presentation at the American Heart Association (AHA) Scientific Sessions 2022 in Chicago, IL: Nov 5-7, 2022. Racial disparities and geographic variation in anticoagulant treatment among Medicare beneficiaries with...
by [email protected] | Jul 20, 2022 | News & Events
An abstract co-authored by STATinMED was accepted for presentation at the upcoming 2022 Eastern Pulmonary Conference, to be held in Palm Beach, FL: Sept 8-11, 2022. Reduction in hospitalizations following initiation of amikacin liposome inhalation suspension: A...
by [email protected] | Jul 14, 2022 | News & Events
Two abstracts co-authored by STATinMED were accepted for presentation at the upcoming European Society of Cardiology (ESC) Congress 2022 to be held in Barcelona, Spain: Aug 26-29, 2022. Comparison of clinical and economic burden of pulmonary arterial hypertension...
by [email protected] | Jul 1, 2022 | News & Events
ISTH Accepts STATinMED co-authored poster for presentation PB0446: Factors associated with anticoagulant treatment initiation among venous thromboembolism patients with cancer. International Society on Thrombosis and Haemostasis (ISTH) Congress. London, UK: July 9-13,...
by [email protected] | Jun 23, 2022 | News & Events
The STATinMED team co-authored 3 posters for presentation at the EASL International Liver Congress in London, June 22-26. Presentation Number: THU372 Healthcare resource utilization and costs of hepatitis delta in the United States: An analysis of all-payer claims...
by [email protected] | May 20, 2022 | News & Events
The STATinMED team is thrilled to once again participate in Digestive Disease Week (DDW) 2022 in San Diego, CA + virtual: May 21-24, 2022. Presentation Number: 871 Hepatitis delta among commercially insured patients in the United States: An analysis of prevalence,...
